EUVIMEDEUVIMED entdecken
Crossref

Risk factors and pattern of metastatic recurrence after endoscopic resection with additional treatment for esophageal cancer

Ippei Tanaka iD, Waku Hatta iD, Tomoyuki Koike, So Takahashi, Tomohiro Shimada, Takuto Hikichi, Yosuke Toya, Yusuke Onozato, Koichi Hamada, Daisuke Fukushi, Ko Watanabe, Shoichi Kayaba und 19 weitere

Diseases of the Esophagus · 2024

DOI: 10.1093/dote/doae048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases of the Esophagus, 2024. Verfasst von Ippei Tanaka und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Sendai Kousei Hospital, Sendai, Miyagi, Japan. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophagectomy, Neoplasm Recurrence, Local, Lymphatic Metastasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although esophageal cancers invading the muscularis mucosa (pT1a-MM) or submucosa (pT1b-SM) after endoscopic resection (ER) are associated with a risk of lymph node metastasis, details of metastatic recurrence after additional treatment remain unknown. We aimed to identify the risk factors for metastatic recurrence and recurrence patterns in patients receiving additional treatment after ER for esophageal cancer. Between 2006 and 2017, patients with pT1a-MM/pT1b-SM esophageal cancer who underwent ER with additional treatment (esophagectomy, chemoradiotherapy [CRT], and radiation therapy) at 21 institutions in Japan were enrolled. We evaluated the risk factors for metastatic recurrence after ER with additional treatment. Subsequently, the rate and pattern (locoregional or distant) of metastatic recurrence were investigated for each additional treatment. Of the 220 patients who received additional treatment, 57, 125, and 38 underwent esophagectomy, CRT, and radiation therapy, respectively. In the multivariate analysis, lymphatic invasion was the sole risk factor for metastatic recurrence after additional treatment (hazard ratio, 3.50; P = 0.029). Although the risk of metastatic recurrence with additional esophagectomy was similar to that with CRT (hazard ratio, 1.01; P = 0.986), the rate of locoregional recurrence tended to be higher with additional esophagectomy (80.0% (4/5) vs. 36.4% (4/11)), leading to a better prognosis in patients with metastatic recurrence after additional esophagectomy than CRT (survival rate, 80.0% (4/5) vs. 9.1% (1/11)). Patients with lymphatic invasion have a high risk of metastatic recurrence after ER with additional treatment for pT1a-MM/pT1b-SM esophageal cancer. Additional esophagectomy may result in a better prognosis after metastatic recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsEsophagectomyNeoplasm Recurrence, LocalLymphatic MetastasisHumansMaleFemaleAgedRisk FactorsMiddle AgedJapanChemoradiotherapyEsophagoscopyRetrospective StudiesAged, 80 and overNeoplasm Invasiveness

Stichwörter der Autor:innen

additional treatmentendoscopic resectionesophageal cancermetastatic recurrence

Autor:innen und Institutionen

  • Department of Gastroenterology, Sendai Kousei Hospital, Sendai, Miyagi, Japan.
  • Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
  • Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
  • Department of Gastroenterology, Akita University Graduate School of Medicine, Akita, Japan.
  • Department of Gastroenterology, Sendai City Medical Center, Sendai, Miyagi, Japan.
  • Department of Endoscopy, Fukushima Medical University Hospital, Fukushima, Japan.

ORCID-Profile: Ippei Tanaka, Waku Hatta

Zitieren

APA

Tanaka, I., Hatta, W., Koike, T., Takahashi, S., Shimada, T., Hikichi, T., Toya, Y., Onozato, Y., Hamada, K., Fukushi, D., Watanabe, K., Kayaba, S., Ito, H., Tatsuta, T., Oikawa, T., Takahashi, Y., Kondo, Y., Yoshimura, T., Shiroki, T., …, & Hirasawa, D. (2024). Risk factors and pattern of metastatic recurrence after endoscopic resection with additional treatment for esophageal cancer. Diseases of the Esophagus. https://doi.org/10.1093/dote/doae048

Vancouver

Tanaka I, Hatta W, Koike T, Takahashi S, Shimada T, Hikichi T, et al. Risk factors and pattern of metastatic recurrence after endoscopic resection with additional treatment for esophageal cancer. Diseases of the Esophagus. 2024. doi:10.1093/dote/doae048

BibTeX
@article{Tanaka2024,
  author = {Tanaka, Ippei and Hatta, Waku and Koike, Tomoyuki and Takahashi, So and Shimada, Tomohiro and Hikichi, Takuto and Toya, Yosuke and Onozato, Yusuke and Hamada, Koichi and Fukushi, Daisuke and Watanabe, Ko and Kayaba, Shoichi and Ito, Hirotaka and Tatsuta, Tetsuya and Oikawa, Tomoyuki and Takahashi, Yasushi and Kondo, Yutaka and Yoshimura, Tetsuro and Shiroki, Takeharu and Nagino, Ko and Hanabata, Norihiro and Funakubo, Akira and Ohira, Tetsuya and Nakamura, Jun and Nakamura, Tomohiro and Nakaya, Naoki and Iijima, Katsunori and Matsumoto, Takayuki and Fukuda, Shinsaku and Masamune, Atsushi and Hirasawa, Dai},
  title = {Risk factors and pattern of metastatic recurrence after endoscopic resection with additional treatment for esophageal cancer},
  journal = {Diseases of the Esophagus},
  year = {2024},
  doi = {10.1093/dote/doae048}
}
Kostenlos starten →